M·CAM | All Post
22144
blog,paged,paged-22,ajax_fade,page_not_loaded,,select-theme-ver-4.1,wpb-js-composer js-comp-ver-7.9,vc_responsive

M·CAM, Inc. releases Patently Obvious® on Celgard, LLC v. Sumitomo Chemical Co., Ltd.

Date:  Thu, 2013-02-28

CHARLOTTESVILLE, VA – February 28, 2013 – M·CAM, Inc. released its Patently Obvious® report today on Celgard, LLC v. Sumitomo Chemical Co., Ltd.

On February 22, 2013, Celgard, LLC filed a patent infringement claim against Sumitomo Chemical Co., Ltd. The complaint accuses Sumitomo of infringing Celgard’s U.S. Pat. No. 6,432,586 (hereafter ”˜586), which covers a separator technology for use in lithium ion batteries. Sumitimo is accused of willful infringement of the ”˜586 patent particularly through its sale of separators to Panasonic for use in the Toughbook line mobile computers.

Using the M·CAM DOORS™ analytic platform, an intellectual property analysis of Celgard’s ”˜586 patent was conducted in order to understand its strength and defensibility in the face of prior and concurrent art innovation. The innovation space surrounding the ”˜586 patent and its patent family members was examined to determine which patent or patents may provide alternatives to or alter the value of Celgard’s holdings.

M·CAM’s Patently Obvious® is a report providing visibility into potentially unconsidered alternatives, including art in the public domain, to patent holdings across a variety of technology areas.

M·CAM, Inc. is a global, full-service intellectual property and rights (IP&R) and intangible asset financial services firm. We provide the technical and financial systems that allow public and private markets to use IP&R and IA for regulated transactions in banking, securities, insurance, and public innovation investment and technology procurement. From our pioneering work in creating the world’s first standards-based innovation collateralization financial products for banking and securities to our work in grassroots innovator enablement and patent quality assurance programs, M·CAM provides the mechanism to balance the interests of public and commercial sectors to support and build thriving economies.

The M·CAM Patently Obvious® report on Celgard’s patent can be found HERE.

OECD Video Footage: Dr. Martin’s Speech on “Bank Lending and the Crisis: Unlocking the Collateral Value of Knowledge Capital”

Date:  Tue, 2013-02-19

Last week Dr. David Martin spoke at the OECD Conference in Paris on “Growth, Innovation, and Competitiveness – Maximizing the Benefits of Knowledge-Based Capital”. Below you can find a link to the video coverage of his speech; “Bank Lending and the Crisis: Unlocking the Collateral Value of Knowledge Capital”.

OECD Video Coverage

Dr. David Martin to Participate in OECD Conference on Growth, Innovation, and Competitiveness (February 13 – 14, 2013)

Date:  Tue, 2013-02-12

Dr. David Martin, Chairman of M·CAM, Inc. is set to speak in the OECD Conference on “Growth, Innovation, and Competitiveness – Maximizing the Benefits of Knowledge-Based Capital” on February 13-14, 2013 in Paris, France. Dr. Martin will deliver a presentation on “Bank Lending and the Crisis: Unlocking the Collateral Value of Knowledge Capital.” Investment and growth in OECD economies is accelerated by knowledge based capital (KBC). The conference will unite some of the world’s top Banking Regulators and Senior Policy Makers to discuss three types of KBC: computerized information, intellectual property, and economic competencies. The expansive shift taking place within the world’s knowledge economies reflects a variety of long-term economic and institutional transformations where organizations invest as much or more in KBC as they do in physical capital. This boost of KBC produces new challenges for policy makers, businesses, and for the ways in which economic activity is measured. Business leaders will explain how KBC is shaping their industries and business models by reviewing state-of-the-art research and policy experiments, and by spotlighting gaps in the development of policy.

For the full OECD Conference agenda and complete line up of speakers, (including long-time friend and partner of M·CAM, Inc, Nick Drake of TBWA/Chiat Day), please visit HERE.

Dr. Martin’s public comments issued during Friday’s USPTO event

Date:  Tue, 2013-01-15

CHARLOTTESVILLE, VA – Did you miss the live Webinar of the Dr. David Martin’s USPTO Roundtable Public Comments on Proposed Requirements for Recordation of Real-Party-in-Interest Information Throughout the Application Pendency on Friday? If so, you are in luck. Today we are releasing Dr. Martin’s public comments issued during Friday’s USPTO event. To read the comments in full, please visit HERE.

Click to download the video: http://helix-1.uspto.gov/asxgen/2013-0111EditedRoundtableonRPI.wmv

Dr. David Martin to participate in the USPTO Roundtable TODAY on Proposed Requirements for Recordation of Real-Party-in-Interest Information Throughout the Application Pendency & Patent Term

Date:  Fri, 2013-01-11

ALEXANDRIA, VA — Dr. David Martin will participate in the USPTO Roundtable this morning in Alexandria, Virginia on Proposed Requirements for Recordation of Real-Party-in-Interest Information Throughout the Application Pendency & Patent Term. The Roundtable discussion will commence at 8:30 AM EST and will be streamed as an open WebEx Webinar. The access information for the event is as follows:

Event Number: 994-604-638 Event Password: 123456 Event Address: https://uspto-events.webex.com/uspto-events/onstage/g.php?t=a&d=994604638

Dr. David Martin featured in “Google Dodges a Bullet at FTC” Financial Times Story (01/04/2013)

Date:  Tue, 2013-01-08

Last Friday the FTC announced they’ve closed a two-year investigation into Google for anti-trust violations, resulting in only minor changes to the search giant’s business practices. Dr. David Martin was featured in the Financial Times story “Google Dodges a Bullet at FTC” by Richard Waters where he commented “It is more a shot across the bow [by regulators] than anything substantive. The exact amount this will ultimately cost Google in practice is not determined, but according to reports, the search engine giant “wasn’t giving up much” to make this gesture of goodwill to the FTC. The full story can be found HERE

Dr. David Martin’s Appearance on The Traders Network Radio Program/Clear Channel-Dallas (12/28/2012)

Date:  Fri, 2012-12-28

Last Friday (12/28/2012) Dr. David Martin spoke with Michael Yorba of Yorba Media about the inner workings of M·CAM, Inc., Kodak and Alcatel-Lucent’s patent portfolios, social media patents and the on-going Apple/Samsung smartphone patent wars. To listen to the full interview, please see below:

click here to download or listen on your mobile device

Preliminary European Parliament Report Published

Date:  Thu, 2012-12-27

BRUSSELS, BE & CHARLOTTESVILLE, VA – M·CAM releases Preliminary Report commissioned by The Greens | European Free Alliance consortium within the European Parliament entitled, “Questionable Outputs from the European Patent Office: EPO Strains on EPC Articles 52 and 53.”

In December 2012, M∙CAM, Inc. was tasked by The Greens|EFA in the European Parliament to analyze, on a preliminary basis, certain outputs of the European Patent Office (EPO) that may be problematic in the context of the patentability standards of the European Patent Convention (EPC), Articles 52 and 53. To do so, M∙CAM aggregated a total of 482,102 patent issuances from the United States Patent and Trademark Office (USPTO) in eighteen selected US classification codes, and determined if European equivalents for any of those documents existed.

Read the Full Report HERE.

M·CAM, Inc. releases Patently Obvious® Bulletin on the Alcatel-Lucent Financing

Date:  Fri, 2012-12-21

CHARLOTTESVILLE, VA December 21, 2012 – M·CAM, Inc. released its Patently Obvious® Bulletin on the Alcatel-Lucent Financing

Alcatel-Lucent’s (ALU) financial troubles drove it to seek financing from Credit Suisse and Goldman Sachs this quarter. Since the struggling telecom company is unable to slow its cash burn, ALU may use its 29,000 patent portfolio as security for $2.1 billion of senior secured financing. They include the intellectual property (IP) originally developed by Bell Labs. Earlier this year, ALU attempted to monetize its portfolio by announcing a preliminary deal with RPX, but as yet no formal deal has been announced. This Patently Obvious™ Bulletin exposes critical information which could impact the proposed transaction.

ALU needs better visibility into where the real commercial values exist in their IP portfolio. As they pursue this financing, the company would be well served to actually identify its real market opportunities as well as the stringent regulatory controls on their assets. There are specific legal and security concerns for ALU as it ponders the use of its IP as security for the credit it seeks. Both the United States (U.S.) and French governments have cause to be concerned on any potential transfer of national security-related IP, which ALU has in great volume. Both governments have the means to prevent the deal from going through.

M·CAM’s Patently Obvious® is a weekly report providing visibility into potentially unconsidered alternatives, including art in the public domain, to patent holdings across a variety of technology areas.

M·CAM, Inc. is a global, full-service intellectual property and rights (IP&R) and intangible asset financial services firm. We provide the technical and financial systems that allow public and private markets to use IP&R and IA for regulated transactions in banking, securities, insurance, and public innovation investment and technology procurement. From our pioneering work in creating the world’s first standards-based innovation collateralization financial products for banking and securities to our work in grassroots innovator enablement and patent quality assurance programs, M·CAM provides the mechanism to balance the interests of public and commercial sectors to support and build thriving economies.

The M·CAM Patently Obvious® Bulletin on the Alcatel-Lucent Financing can be found HERE.

M·CAM, Inc. releases the 7th edition of The Navigare Newsletter

Date:  Tue, 2012-12-18

Today M·CAM, Inc. released the 7th edition of The Navigare — one of the most fascinating editions to date. Inside this volume readers will learn what modern day sentiment analysis is lacking, hear the latest updates from our collaboration with the Kevin Rohan Memorial Eco Foundation, discover an alternative logic for assessing value, and become acquainted with Hylo, an idea accelerator that helps people imagine and build together within and between communities of purpose — To name a few topics covered inside this edition of The Navigare. If you are interested in being added to our newsletter mailing list, please contact Denise Holman at dlh@m-cam.com.

Download a copy HERE or view as a magazine HERE

Bloomberg West Lead Story Featuring M-CAM’s Dr. David Martin: “Google, Apple to Pay More Than $500M for Patents”

M·CAM’s Dr. David Martin appeared LIVE tonight on Bloomberg Television in the lead story. Dr. Martin’s commentary focused on the market consequences of Kodak’s recent financial and patent activities. The Kodak digital imaging sale, if it closes, would effectively be the death of the battles over still imaging. The combat will now move onto more advanced sectors like high quality, high definition, streaming video.

Also, to read more about M·CAM’s understanding of the Kodak portfolio, please read our most recent Patently Obvious® Reports:

M·CAM, Inc. releases Patently Obvious® on Kodak and the $500 Million Provisional Bid

M·CAM, Inc. releases Patently Obvious® on the Eastman Kodak $830m Financing Offer

Dr. David Martin to Appear LIVE on Bloomberg Tonight Discussing Google and Apple’s Interest in Purchasing Kodak Patents

Date:  Sun, 2012-12-09

TONIGHT at 6:00 PM EST Dr. David Martin will be appearing LIVE on Bloomberg Television where he will be discussing Google and Apple’s plans to team up to buy Kodak’s digital imaging patent portfolio for more than $500M. Dr. Martin will be providing his insight as to why these two entities may be joining forces to buy the digital imaging patents and the negative effects that could have on public policy. The LIVE footage can be viewed HERE.

To read more about M·CAM’s understanding of the Kodak portfolio, please read our most recent Patently Obvious® Reports:

M·CAM, Inc. releases Patently Obvious® on Kodak and the $500 Million Provisional Bid

M·CAM, Inc. releases Patently Obvious® on the Eastman Kodak $830m Financing Offer

M·CAM, Inc. releases Patently Obvious® on Kodak and the $500 Million Provisional Bid

Date:  Fri, 2012-12-07

CHARLOTTESVILLE, VA December 07, 2012 – M·CAM, Inc. released its Patently Obvious® report today on Kodak and the $500 Million Provisional Bid.

While this just may be the next reel in the on-going saga of Kodak’s celluloid dream of destiny initiated when management shunned digital imaging in favor of believing that film would die a much slower death than the market had ordained, this movie is getting more unfocused each day. And to think that it’s all playing out under the cataract-clouded eyes of the Federal Trade Commission and the U.S. Department of Justice – neither of whom could actually review this transaction for its anti-competitive effects EVEN IF the material identities of the participants were disclosed. Kodak’s “color management” strategy of the last decade has become message mismanagement and how colorful it’s become. And under the sympathetic bench of U.S. District Judge Harold Baer who dismissed a shareholder lawsuit in early November in which damaged parties alleged that Kodak had made “false and misleading statements”, it appears that Lady Justice is having a “wardrobe malfunction” that would make Janet Jackson and John Ashcroft blush.

M·CAM’s Patently Obvious® is a report providing visibility into potentially unconsidered alternatives, including art in the public domain, to patent holdings across a variety of technology areas.

M·CAM, Inc. is a global, full-service intellectual property and rights (IP&R) and intangible asset financial services firm. We provide the technical and financial systems that allow public and private markets to use IP&R and IA for regulated transactions in banking, securities, insurance, and public innovation investment and technology procurement. From our pioneering work in creating the world’s first standards-based innovation collateralization financial products for banking and securities to our work in grassroots innovator enablement and patent quality assurance programs, M·CAM provides the mechanism to balance the interests of public and commercial sectors to support and build thriving economies.

The M·CAM Patently Obvious® report on Kodak and the $500 million provisional bid can be found HERE.

M·CAM, Inc. releases Patently Obvious® on the Eastman Kodak $830m Financing Offer

Date:  Fri, 2012-11-30

CHARLOTTESVILLE, VA November 30, 2012 – M·CAM, Inc. released its Patently Obvious® report today on the Eastman Kodak $830m Financing Offer

When the Steering Committee of the Second Lien Noteholder’s Committee offered to provide Kodak with an $830 million loan, an offer that was accepted by the company on November 30, 2012, it probably acted in good faith. What’s wrong with the Committee’s offer? For starters, the mandatory sale for $500 million may or may not happen. It may be that certain patent aggregators are angling to benefit from out-bidding the late summer order-of-magnitude discount with a complex set of litigation avoidance licenses which may add up to the price target. Whether the Department of Justice and Federal Trade Commission’s public workshop on Patent Assertion Entities on December 10, 2012 tempers this strategy remains to be seen. Whether the DoJ actually decides to take the Sherman Act seriously or not will undoubtedly impact the ultimate market value (to Kodak or the unlucky buyer). In any case, it’s reasonable to assume that Lasinski’s stratospheric valuation will suffer an unintended demise and unlike Marat’s, this one will be self-inflicted.

The M·CAM Patently Obvious® report on the Eastman Kodak $830m financing offer can be found HERE.

Dr. David Martin Interviewed by OffPlanet Radio’s Randy Maugans (11/25/2012)

Date:  Tue, 2012-11-27

On Sunday, Dr. David Martin was interviewed by OffPlanet Radio’s Randy Maugans about the present day economic system, why it will not finance its own demise, and the alternative perspective to genuine breakthrough. To listen to the entire interview, please visit http://offplanetradio.com/podcast/david-martin-global-breakthrough-energ… or

See video

.

To download the full audio, please visit: http://www.divshare.com/direct/20958865-b06.mp3

Chairman Dr. David Martin Quoted in Financial Times Regarding Apple/HTC Settlement

CHARLOTTESVILLE, VA – Read M·CAM Chairman Dr. David Martin’s thoughts on Apple/HTC settlement in Tim Bradshaw’s Financial Times article, “Apple saves its big guns for Samsung”.

“This settlement and their statement on Friday don’t quite jive,” says David Martin, Founder and Chief Executive of M·CAM. “Apple is starting to look at the market consequence of their litigation strategy and realizing there may be some blow back from it.”

To read the full article, please visit: http://www.ft.com/intl/cms/s/0/da7acd2c-2c2d-11e2-a91d-00144feabdc0.html…

Live Stream Breakthrough Energy Movement Conference

Date:  Sat, 2012-11-10

Dr. David Martin is participating in the International Breakthrough Energy Movement (BEM) Conference this weekend in Amsterdam. The conference will address challenges humanity faces that are systemic and grounded in archaic systems and structures in the areas of energy, economy, government, social, and environmental. Dr. Marin’s presentation at the BEM conference is entitled “Quantum Disentanglement: Emancipating the Economics from Edison and Einstein to Everyone” and he will unveil the anatomy of the incumbent systems of economic controls and present a practical plan to an ethical framework for Phase and State Coherent Economical Power at Human Scale. To listen to the live stream event for $20.00, please visit: http://globalbem.com/stream